Sputtr.com | Alternative Search Engine


What is in this leaflet

REVIA ® Naltrexone hydrochloride (nal-TREX-own) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about REVIA®

Informed Consent for Medication, F-24277, ReVia

Client Initial Date DEPARTMENT OF HEALTH SERVICES Division of Mental Health and Substance Abuse Services F-24277 (12/2010) STATE OF WISCONSIN 42 CFR483.420(a) (2) DHS 134.31(3)(o) DHS 94.03 & 94.09 s.51.61(1)(g) & (h ) INFORMED CONSENT FOR MEDICATION Dosage and / or Side Effect information last ...

Patient Education NALTREXONE HCL - ORAL

NALTREXONE HCL - ORAL (nal-TREX-own) COMMON BRAND NAME(S): Revia WARNING: Naltrexone can cause liver problems when given in doses that are too large.

Canadian Expert Drug Advisory Committee Final Recommendation ...

CEDAC Recommendation CEDAC recommended that Campral be listed for coverage by Canada's publicly funded drug plans only for patients who have not been drinking any alcohol for at least four days and who are unable to take ReVia™ (naltrexone) - another drug used to help people dependant on alcohol.

A SNPMapoftheRat Genome Generated fromcDNA Sequences

Strain No. of bp screened No. of candidate SNPs SHRSPversusBN 5,114,620 4,748 WKYversusBN 4,699,327 4,138 SDversusBN 3,557,619 2,765 WKYversusSHRSP 478 WKYversusSD 407 SHRSPversusSD 449 Total 13,371,566 12,985 B REVIA www.sciencemag.org SCIENCE VOL 303 6FEBRUARY 2004 807

Naltrexone Authorization A

Health Care Authority (HCA) provides coverage for a REVIA® prescription up to 12 weeks. The patient must be currently enrolled in a state-certified chemical dependency treatment program and meet the Medicaid Prescription Drug Program criteria at:

The Efficacy of Antabuse, Campral, and Naltrexone in Treating ...

Efficacy of Antabuse - 3 TABLE 1 Opioid Antagonists Name Naltrexone Naloxone Nalmefene Brand Name Revia Narcan Revex Rte of Admin Oral Injection Oral or Injection Use Opiate Tx and Alcohol Tx Opiate OD Opiate Tx and Opiate OD and Alcohol Tx FDA Approved 1984 Opiate Tx 1994 Alcohol Tx 1971 1995 Discontinued Receptor (s) Mu ...

Medications and Alcohol Craving

Three of the four medications approved in the United States or Europe for treating alcoholism are reported to reduce craving; these include naltrexone (ReVia ™), acamprosate, and tiapride.

Bottom-Feeding Plesiosaurs

J. Wiffen, V. de Buffrenil, A. de Ricqles, J.-M. Mazin, Geobios 28,625 (1995). 11 July2005; accepted 7 September 2005 10.1126/science. 1117241 B REVIA 1 School of Environmental and Life Sciences (Geology) University of Newcastle, New South Wales 2308, Australia. 2 Geology, Queensland Museum, Post Office Box ...

Substance Abuse Treatment Advisory

Table 1: Comparison of Drugs Approved for Maintenance of Abstinence From Alcohol Medication Acamprosate (Campral) Disulfiram (Antabuse) Naltrexone (ReVia) Mechanism of Action Is not completely understood; appears to modulate/normalize alcohol-disrupted brain activity, particularly in the GABA and glu­ tamate ...